featured
Supreme DES With Early Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After Implantation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Circulation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Novel SupremeTM DES With Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After DES Implantation in Coronary Artery Disease: Results of the PIONEER III Randomized Clinical Trial
Circulation 2021 Apr 06;[EPub Ahead of Print], AJ Lansky, DJ Kereiakes, A Baumbach, S Windecker, Y Hussain, C Pietras, O Dressler, O Issever, M Curtis, B Bertolet, JP Zidar, PC Smits, VA Jiménez Díaz, B McLaurin, S Hofma, Á Cequier, N Dib, E Benit, A Mathur, D Brogno, J Berland, J Wykrzykowska, G Piegari, S Brugaletta, S Saito, MB LeonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.